# Intravenous NAC Use in ACLF Patients

> **NCT05089981** · NA · UNKNOWN · sponsor: **Aga Khan University** · enrollment: 100 (estimated)

## Conditions studied

- Acute on Chronic Liver Failure(ACLF)

## Interventions

- **DRUG:** N acetyl cysteine
- **DRUG:** Placebo of N acetyl cysteine

## Key facts

- **NCT ID:** NCT05089981
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089981, "Intravenous NAC Use in ACLF Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05089981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*